心脏事务：心血管研究与开发中的创新

Affairs of the Heart: Innovation in Cardiovascular Research and Development.

作者信息

Honig P, Terzic A

机构信息

Collegeville, Pennsylvania, USA.

Center for Regenerative Medicine, Departments of Cardiovascular Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Clin Pharmacol Ther. 2017 Aug;102(2):162-168. doi: 10.1002/cpt.737.

DOI:10.1002/cpt.737

PMID:28718903

Abstract

Cardiovascular disease represents the single largest contributor to morbidity and mortality, yet the flow of therapeutic innovation is lagging. Globally, academia, industry, and regulatory agencies must work together to address this gap, and ensure new disruptive therapeutic modalities to address growing needs of patients and society.

摘要

心血管疾病是导致发病和死亡的最大单一因素，然而治疗创新的进程却滞后了。在全球范围内，学术界、产业界和监管机构必须共同努力来弥补这一差距，并确保有新的突破性治疗方式来满足患者和社会日益增长的需求。